Valuation: UCB

Market Cap 42.21B 48.57B 39.41B 36.18B 68.22B 4,630B 69.41B 465B 182B 2,309B 182B 178B 7,615B P/E 2026 *
22.6x
P/E 2027 * 18.4x
Enterprise Value 42.43B 48.82B 39.61B 36.36B 68.57B 4,653B 69.76B 467B 183B 2,320B 183B 179B 7,654B EV / Sales 2026 *
4.91x
EV / Sales 2027 * 4.16x
Free-Float
61.59%
Yield 2026 *
0.66%
Yield 2027 * 0.68%
1 day+1.54%
1 week-10.15%
Current month+0.85%
1 month-11.64%
3 months-1.62%
6 months-15.65%
Current year-5.78%
1 week 214
Extreme 214
251.5
1 month 214
Extreme 214
260.4
Current year 214
Extreme 214
289.5
1 year 181.15
Extreme 181.15
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%-10.15%+21.74%+182.55% 48.57B
-0.44%+13.80%+35.85%-1.58% 75.81B
-4.18%+42.30%+42.30%+42.30% 46.01B
+3.64%+7.79%-51.37%-51.41% 41.66B
-0.56%+0.84%+52.95%-24.62% 29.82B
-0.91%-0.37%+56.67%+82.26% 24.01B
+0.58%-0.88%+99.75%-49.85% 22.01B
+0.81%-3.56%-6.67%+164.33% 19.09B
-0.18%-6.77%+61.30%+115.23% 15.83B
-0.16%-4.95%+68.80%+149.10% 15.63B
Average +0.01%-1.26%+38.13%+60.83% 33.84B
Weighted average by Cap. -0.04%+0.67%+31.42%+47.23%

Financials

2026 *2027 *
Net sales 8.64B 9.95B 8.07B 7.41B 13.97B 948B 14.21B 95.16B 37.27B 473B 37.36B 36.53B 1,559B 9.7B 11.16B 9.06B 8.31B 15.68B 1,064B 15.95B 107B 41.82B 530B 41.92B 40.99B 1,750B
Net income 1.86B 2.14B 1.74B 1.6B 3.01B 204B 3.06B 20.49B 8.03B 102B 8.05B 7.87B 336B 2.34B 2.69B 2.18B 2B 3.78B 256B 3.84B 25.72B 10.07B 128B 10.1B 9.88B 422B
Net Debt 216M 248M 201M 185M 349M 23.65B 355M 2.37B 930M 11.79B 932M 911M 38.9B -1.9B -2.18B -1.77B -1.63B -3.07B -208B -3.12B -20.89B -8.18B -104B -8.2B -8.02B -342B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-08-04 225.80 +1.99% 55,990
26-08-03 €221.40 -0.67% 305,551
26-07-31 €222.90 +2.72% 497,579
26-07-30 €217.00 -13.51% 857,389
26-07-29 €250.90 +0.28% 171,258
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
221.40EUR
Average target price
286.11EUR
Spread / Average Target
+29.23%

Quarterly revenue - Rate of surprise